跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
401-4
首页
药物
401-4
401-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Hydroxylated tolans and related compounds in the treatment of a cancer
US 8716355 B2
申请人: TSAI CHUN-CHE
优先权: 2008
US
2 件公开
Biological sample magnetic-enrichment instrument
CN 203007279 U
申请人: UNIV SHANGHAI
优先权: 2013
CN
Quantify black device of joining of production
CN 206026725 U
申请人: XIE HUIYONG
优先权: 2016
CN
一种新型AB型苯并噁嗪单体及其制备方法
CN 109776518 B
申请人: 江苏大学
优先权: 2019
CN
Extraction device of 1-phenylpyridine
CN 214808592 U
申请人: NANJING WEIXIN BIOLOGICAL MEDICINE CO LTD
优先权: 2020
CN
Antigen applicable to production of anti-cryptochrome 4 antibody
CN 114316011 A
申请人: MILITARY SCIENCE INST MILITARY MEDICINE INST AND MILITARY VETERINARY INST
优先权: 2021
CN
EVT-401 in-vivo glucuronized metabolite M3, derivative thereof, preparation method and application thereof
CN 118666922 A
申请人: ZHEJIANG JINHUA CONBA BIO PHARM CO LTD
优先权: 2024
CN
In-vivo oxidative metabolite M4 of EVT-401 medicine, analogue thereof, and preparation method and application of in-vivo oxidative metabolite M4 and analogue thereof
CN 118666749 A
申请人: ZHEJIANG JINHUA CONBA BIO PHARM CO LTD
优先权: 2024
CN
Establishment, optimization and application of efficient betula platyphylla gene editing system
CN 120099072 A
申请人: UNIV NORTHEAST FORESTRY
优先权: 2024
CN
一种病理微环境自驱动靶向的纳米机器人及其制备方法和应用
CN 121197100 B
申请人: 重庆医科大学附属口腔医院(重庆市口腔医院)
优先权: 2025
CN
药物
反馈